|
US5807A
(en)
|
|
1848-09-26 |
|
Brake fob cabs |
|
US715A
(en)
|
|
1838-04-28 |
|
Improvement in water-wheels |
|
US823244A
(en)
|
1906-01-18 |
1906-06-12 |
Emerson Mfg Co |
Wheeled plow.
|
|
US4179337A
(en)
|
1973-07-20 |
1979-12-18 |
Davis Frank F |
Non-immunogenic polypeptides
|
|
JPS6023084B2
(ja)
|
1979-07-11 |
1985-06-05 |
味の素株式会社 |
代用血液
|
|
US4444887A
(en)
|
1979-12-10 |
1984-04-24 |
Sloan-Kettering Institute |
Process for making human antibody producing B-lymphocytes
|
|
US6872868B1
(en)
|
1981-06-12 |
2005-03-29 |
Ohio University |
Transgenic mammals
|
|
US4714681A
(en)
|
1981-07-01 |
1987-12-22 |
The Board Of Reagents, The University Of Texas System Cancer Center |
Quadroma cells and trioma cells and methods for the production of same
|
|
US4474893A
(en)
|
1981-07-01 |
1984-10-02 |
The University of Texas System Cancer Center |
Recombinant monoclonal antibodies
|
|
US4485045A
(en)
|
1981-07-06 |
1984-11-27 |
Research Corporation |
Synthetic phosphatidyl cholines useful in forming liposomes
|
|
US4640835A
(en)
|
1981-10-30 |
1987-02-03 |
Nippon Chemiphar Company, Ltd. |
Plasminogen activator derivatives
|
|
US4716111A
(en)
|
1982-08-11 |
1987-12-29 |
Trustees Of Boston University |
Process for producing human antibodies
|
|
GB8308235D0
(en)
|
1983-03-25 |
1983-05-05 |
Celltech Ltd |
Polypeptides
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US4544545A
(en)
|
1983-06-20 |
1985-10-01 |
Trustees University Of Massachusetts |
Liposomes containing modified cholesterol for organ targeting
|
|
US4496689A
(en)
|
1983-12-27 |
1985-01-29 |
Miles Laboratories, Inc. |
Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer
|
|
US5807715A
(en)
|
1984-08-27 |
1998-09-15 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin
|
|
EP0206448B1
(en)
|
1985-06-19 |
1990-11-14 |
Ajinomoto Co., Inc. |
Hemoglobin combined with a poly(alkylene oxide)
|
|
GB8607679D0
(en)
|
1986-03-27 |
1986-04-30 |
Winter G P |
Recombinant dna product
|
|
US5225539A
(en)
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
|
IN164232B
(enExample)
|
1986-04-11 |
1989-02-04 |
Hoechst India |
|
|
US4695198A
(en)
|
1986-05-23 |
1987-09-22 |
Chevron Research Company |
Lip-type sealing system for a removable bottom founded structure
|
|
US4791192A
(en)
|
1986-06-26 |
1988-12-13 |
Takeda Chemical Industries, Ltd. |
Chemically modified protein with polyethyleneglycol
|
|
EP0256654B1
(en)
*
|
1986-07-07 |
1996-09-18 |
Centocor, Inc. |
Chimeric murine/human immunoglobulin specific for tumour-associated 17-1A Antigen
|
|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
|
US5059680A
(en)
|
1986-11-24 |
1991-10-22 |
Centocor, Inc. |
Method of isolating ca 125 antigen
|
|
US5091513A
(en)
|
1987-05-21 |
1992-02-25 |
Creative Biomolecules, Inc. |
Biosynthetic antibody binding sites
|
|
US5258498A
(en)
|
1987-05-21 |
1993-11-02 |
Creative Biomolecules, Inc. |
Polypeptide linkers for production of biosynthetic proteins
|
|
CA1340927C
(en)
|
1987-10-09 |
2000-03-14 |
Peter S. Linsley |
Method for increasing the sensitivity of assays for target ligand
|
|
IT1212041B
(it)
|
1987-11-02 |
1989-11-08 |
Fidia Farmaceutici |
Gangliosidi esteri interni come agenti terapeutici capaci di eliminare il dolore nelle neuropatie periferiche
|
|
JPH02486A
(ja)
|
1987-11-13 |
1990-01-05 |
Mect Corp |
遊離ｎ−アセチルノイラミン酸を認識するモノクローナル抗体
|
|
US4978745A
(en)
|
1987-11-23 |
1990-12-18 |
Centocor, Inc. |
Immunoreactive heterochain antibodies
|
|
US4975369A
(en)
|
1988-04-21 |
1990-12-04 |
Eli Lilly And Company |
Recombinant and chimeric KS1/4 antibodies directed against a human adenocarcinoma antigen
|
|
US4925648A
(en)
|
1988-07-29 |
1990-05-15 |
Immunomedics, Inc. |
Detection and treatment of infectious and inflammatory lesions
|
|
US5601819A
(en)
|
1988-08-11 |
1997-02-11 |
The General Hospital Corporation |
Bispecific antibodies for selective immune regulation and for selective immune cell binding
|
|
EP1997891A1
(en)
|
1988-09-02 |
2008-12-03 |
Dyax Corporation |
Generation and selection of recombinant varied binding proteins
|
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
DE3920358A1
(de)
|
1989-06-22 |
1991-01-17 |
Behringwerke Ag |
Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
|
|
ATE144793T1
(de)
|
1989-06-29 |
1996-11-15 |
Medarex Inc |
Bispezifische reagenzien für die aids-therapie
|
|
US5413923A
(en)
|
1989-07-25 |
1995-05-09 |
Cell Genesys, Inc. |
Homologous recombination for universal donor cells and chimeric mammalian hosts
|
|
US5013556A
(en)
|
1989-10-20 |
1991-05-07 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
|
US5208020A
(en)
|
1989-10-25 |
1993-05-04 |
Immunogen Inc. |
Cytotoxic agents comprising maytansinoids and their therapeutic use
|
|
GB8928874D0
(en)
|
1989-12-21 |
1990-02-28 |
Celltech Ltd |
Humanised antibodies
|
|
WO1991010737A1
(en)
|
1990-01-11 |
1991-07-25 |
Molecular Affinities Corporation |
Production of antibodies using gene libraries
|
|
US5780225A
(en)
|
1990-01-12 |
1998-07-14 |
Stratagene |
Method for generating libaries of antibody genes comprising amplification of diverse antibody DNAs and methods for using these libraries for the production of diverse antigen combining molecules
|
|
DE69133566T2
(de)
|
1990-01-12 |
2007-12-06 |
Amgen Fremont Inc. |
Bildung von xenogenen Antikörpern
|
|
US6075181A
(en)
|
1990-01-12 |
2000-06-13 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
US5427908A
(en)
|
1990-05-01 |
1995-06-27 |
Affymax Technologies N.V. |
Recombinant library screening methods
|
|
GB9012995D0
(en)
*
|
1990-06-11 |
1990-08-01 |
Celltech Ltd |
Multivalent antigen-binding proteins
|
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
|
US5661016A
(en)
|
1990-08-29 |
1997-08-26 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
|
US5814318A
(en)
|
1990-08-29 |
1998-09-29 |
Genpharm International Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
US6300129B1
(en)
|
1990-08-29 |
2001-10-09 |
Genpharm International |
Transgenic non-human animals for producing heterologous antibodies
|
|
KR100272077B1
(ko)
|
1990-08-29 |
2000-11-15 |
젠팜인터내셔날,인코포레이티드 |
이종 항체를 생산할 수 있는 전이유전자를 가진 인간이외의 동물
|
|
US5625126A
(en)
|
1990-08-29 |
1997-04-29 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
US5633425A
(en)
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5545806A
(en)
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
|
US5698426A
(en)
|
1990-09-28 |
1997-12-16 |
Ixsys, Incorporated |
Surface expression libraries of heteromeric receptors
|
|
AU667460B2
(en)
|
1990-10-05 |
1996-03-28 |
Medarex, Inc. |
Targeted immunostimulation with bispecific reagents
|
|
AU8727291A
(en)
|
1990-10-29 |
1992-06-11 |
Cetus Oncology Corporation |
Bispecific antibodies, method of production, and uses thereof
|
|
WO1992009690A2
(en)
|
1990-12-03 |
1992-06-11 |
Genentech, Inc. |
Enrichment method for variant proteins with altered binding properties
|
|
DE69233750D1
(de)
|
1991-04-10 |
2009-01-02 |
Scripps Research Inst |
Bibliotheken heterodimerer Rezeptoren mittels Phagemiden
|
|
WO1992019973A1
(en)
|
1991-04-26 |
1992-11-12 |
Surface Active Limited |
Novel antibodies, and methods for their use
|
|
DE69233482T2
(de)
|
1991-05-17 |
2006-01-12 |
Merck & Co., Inc. |
Verfahren zur Verminderung der Immunogenität der variablen Antikörperdomänen
|
|
US5565332A
(en)
|
1991-09-23 |
1996-10-15 |
Medical Research Council |
Production of chimeric antibodies - a combinatorial approach
|
|
AU3178993A
(en)
|
1991-11-25 |
1993-06-28 |
Enzon, Inc. |
Multivalent antigen-binding proteins
|
|
US5932448A
(en)
|
1991-11-29 |
1999-08-03 |
Protein Design Labs., Inc. |
Bispecific antibody heterodimers
|
|
ATE408012T1
(de)
|
1991-12-02 |
2008-09-15 |
Medical Res Council |
Herstellung von autoantikörpern auf phagenoberflächen ausgehend von antikörpersegmentbibliotheken
|
|
CA2131528C
(en)
|
1992-03-05 |
2004-07-13 |
Philip E. Thorpe |
Methods and compositions for targeting the vasculature of solid tumors
|
|
US5733743A
(en)
|
1992-03-24 |
1998-03-31 |
Cambridge Antibody Technology Limited |
Methods for producing members of specific binding pairs
|
|
ES2149768T3
(es)
|
1992-03-25 |
2000-11-16 |
Immunogen Inc |
Conjugados de agentes enlazantes de celulas derivados de cc-1065.
|
|
US5639641A
(en)
|
1992-09-09 |
1997-06-17 |
Immunogen Inc. |
Resurfacing of rodent antibodies
|
|
US5951983A
(en)
|
1993-03-05 |
1999-09-14 |
Universite Catholique De Louvain |
Methods of inhibiting T cell mediated immune responses with humanized LO-CD2A-specific antibodies
|
|
US20030108548A1
(en)
|
1993-06-01 |
2003-06-12 |
Bluestone Jeffrey A. |
Methods and materials for modulation of the immunosuppressive activity and toxicity of monoclonal antibodies
|
|
WO1995015982A2
(en)
|
1993-12-08 |
1995-06-15 |
Genzyme Corporation |
Process for generating specific antibodies
|
|
DK1231268T3
(da)
|
1994-01-31 |
2005-11-21 |
Univ Boston |
Polyklonale antistofbiblioteker
|
|
US5516637A
(en)
|
1994-06-10 |
1996-05-14 |
Dade International Inc. |
Method involving display of protein binding pairs on the surface of bacterial pili and bacteriophage
|
|
US5786464C1
(en)
|
1994-09-19 |
2012-04-24 |
Gen Hospital Corp |
Overexpression of mammalian and viral proteins
|
|
US5919652A
(en)
|
1994-11-09 |
1999-07-06 |
The Regents Of The University Of California |
Nucleic acid molecules comprising the prostate specific antigen (PSA) promoter and uses thereof
|
|
US5710038A
(en)
|
1994-11-25 |
1998-01-20 |
Universite De Montreal |
Primary cultures of normal and tumoral human ovarian epithelium
|
|
US5811510A
(en)
|
1995-04-14 |
1998-09-22 |
General Hospital Corporation |
Biodegradable polyacetal polymers and methods for their formation and use
|
|
JP4312259B2
(ja)
|
1995-04-27 |
2009-08-12 |
アムジェン フレモント インク． |
免疫したゼノマウス（ＸｅｎｏＭｏｕｓｅ）に由来するヒト抗体
|
|
EP0823941A4
(en)
|
1995-04-28 |
2001-09-19 |
Abgenix Inc |
HUMAN ANTIBODIES DERIVED FROM IMMUNIZED XENO MOUSES
|
|
US5733920A
(en)
|
1995-10-31 |
1998-03-31 |
Mitotix, Inc. |
Inhibitors of cyclin dependent kinases
|
|
JP2978435B2
(ja)
|
1996-01-24 |
1999-11-15 |
チッソ株式会社 |
アクリロキシプロピルシランの製造方法
|
|
US5849733A
(en)
|
1996-05-10 |
1998-12-15 |
Bristol-Myers Squibb Co. |
2-thio or 2-oxo flavopiridol analogs
|
|
WO1998000711A1
(en)
|
1996-07-03 |
1998-01-08 |
Millenium Pharmaceuticals, Inc. |
Detection of cancer by assaying for cancer-specific antigens having linked oligosaccharides which are at least triantennary
|
|
US6114148C1
(en)
|
1996-09-20 |
2012-05-01 |
Gen Hospital Corp |
High level expression of proteins
|
|
US5916771A
(en)
|
1996-10-11 |
1999-06-29 |
Abgenix, Inc. |
Production of a multimeric protein by cell fusion method
|
|
US6348584B1
(en)
|
1996-10-17 |
2002-02-19 |
John Edward Hodgson |
Fibronectin binding protein compounds
|
|
DE69738539T2
(de)
|
1996-12-03 |
2009-03-26 |
Amgen Fremont Inc. |
Vollkommen humane Antikörper die EGFR binden
|
|
BRPI9809391B8
(pt)
|
1997-04-14 |
2021-05-25 |
Amgen Res Munich Gmbh |
processo para a produção de um receptor de antígeno anti-humano, anticorpo humano e composição farmacêutica
|
|
US6235883B1
(en)
|
1997-05-05 |
2001-05-22 |
Abgenix, Inc. |
Human monoclonal antibodies to epidermal growth factor receptor
|
|
EP0985039B1
(en)
|
1997-06-12 |
2008-02-20 |
Novartis International Pharmaceutical Ltd. |
Artificial antibody polypeptides
|
|
WO1999014353A2
(en)
|
1997-09-19 |
1999-03-25 |
Dana-Farber Cancer Institute, Inc. |
Intrabody-mediated control of immune reactions
|
|
JP2002500879A
(ja)
|
1998-01-23 |
2002-01-15 |
イムクローン システムズ インコーポレーテッド |
幹細胞の精製ポピュレーション
|
|
AU2472400A
(en)
|
1998-10-20 |
2000-05-08 |
City Of Hope |
CD20-specific redirected T cells and their use in cellular immunotherapy of CD20+ malignancies
|
|
US20030170249A1
(en)
|
1999-02-19 |
2003-09-11 |
Hakomori Sen-Itiroh |
Vaccines directed to cancer-associated carbohydrate antigens
|
|
US20020012660A1
(en)
|
1999-03-04 |
2002-01-31 |
Alan Colman |
Method of preparing a somatic cells for nuclear transfer
|
|
GB2344886B
(en)
|
1999-03-10 |
2000-11-01 |
Medical Res Council |
Selection of intracellular immunoglobulins
|
|
AU5744800A
(en)
|
1999-06-16 |
2001-01-02 |
Biocrystal Limited |
Vaccine formulations and methods for immunizing an individual against shed antigen-specific b cells
|
|
EP1642909A3
(en)
|
1999-12-06 |
2006-04-12 |
Agensys, Inc. |
Serpentine transmembrane antigens expressed in human prostate cancers and uses thereof
|
|
WO2001043778A1
(en)
|
1999-12-17 |
2001-06-21 |
Gene Therapy Systems, Inc. |
Use of cationic lipids for intracellular protein delivery
|
|
US20030008813A1
(en)
|
1999-12-17 |
2003-01-09 |
Felgner Philip L. |
Intracellular protein delivery compositions and methods of use
|
|
US7279294B2
(en)
|
2000-04-03 |
2007-10-09 |
The United States Of America As Represented By The Secretary, Dept. Of Health And Human Services, Nih |
Tumor markers in ovarian cancer
|
|
IT1317922B1
(it)
|
2000-10-24 |
2003-07-15 |
S I S S A Scuola Internaz Supe |
Metodo per identificare in vivo epitopi intracellulari.
|
|
EP1334188B1
(en)
|
2000-11-07 |
2006-08-30 |
City of Hope |
Cd19-specific redirected immune cells
|
|
US20030104402A1
(en)
|
2001-01-23 |
2003-06-05 |
University Of Rochester |
Methods of producing or identifying intrabodies in eukaryotic cells
|
|
AU2002233619A1
(en)
|
2001-02-26 |
2002-09-12 |
Zur Pierre Beserman |
Systems devices and methods for intrabody targeted delivery and reloading of therapeutic agents
|
|
GB0108165D0
(en)
|
2001-03-31 |
2001-05-23 |
Univ Manchester |
Intracellular analysis
|
|
US7514537B2
(en)
|
2001-04-30 |
2009-04-07 |
City Of Hope |
Chimeric immunoreceptor useful in treating human gliomas
|
|
CA2445746C
(en)
|
2001-04-30 |
2012-09-18 |
City Of Hope |
Chimeric immunoreceptor useful in treating human cancers
|
|
WO2002088351A1
(en)
|
2001-04-30 |
2002-11-07 |
Rbc Biotechnology, Inc. |
Modified organs and cells for xenotransplantation
|
|
US20090257994A1
(en)
|
2001-04-30 |
2009-10-15 |
City Of Hope |
Chimeric immunoreceptor useful in treating human cancers
|
|
KR100486784B1
(ko)
|
2001-05-22 |
2005-04-29 |
김하형 |
솔비나무로 부터 추출된 렉틴 단백질, 그의 제조방법 및용도
|
|
AU2002316162A1
(en)
|
2001-05-24 |
2002-12-03 |
Immucom Inc. |
Method of increasing anti-neugc antibody levels in blood
|
|
US6814734B2
(en)
|
2001-06-18 |
2004-11-09 |
Sdgi Holdings, Inc, |
Surgical instrumentation and method for forming a passage in bone having an enlarged cross-sectional portion
|
|
JP4355571B2
(ja)
|
2001-07-19 |
2009-11-04 |
ウニベルジテート チューリッヒ |
ヒト可変ドメインの改変
|
|
JP2004538324A
(ja)
|
2001-08-03 |
2004-12-24 |
メディカル リサーチ カウンシル |
細胞内抗体
|
|
EP1419176A2
(en)
|
2001-08-17 |
2004-05-19 |
Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts |
Glycoconjugates of sialic acid derivates, methods for their production and use thereof
|
|
WO2003040185A2
(de)
|
2001-11-09 |
2003-05-15 |
Hexal Biotech Forschungsgmbh |
Anti-n-glykolyl-neuraminsäure-antikörper und ihre verwendung zur bestimmung von glykoproteinen
|
|
AU2002364586A1
(en)
|
2001-12-21 |
2003-07-30 |
Delta Biotechnology Limited |
Albumin fusion proteins
|
|
JP4291696B2
(ja)
|
2002-01-22 |
2009-07-08 |
ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー |
２−（ピリジン−２−イルアミノ）−ピリド［２，３−ｄ］ピリミジン−７−オン
|
|
GB0201611D0
(en)
|
2002-01-24 |
2002-03-13 |
Grosveld Frank |
Transgenic animal
|
|
GB0226723D0
(en)
|
2002-11-15 |
2002-12-24 |
Medical Res Council |
Antibodies for in vitro use
|
|
AU2003219277A1
(en)
|
2002-03-14 |
2003-09-29 |
Medical Research Council |
Intracellular antibodies
|
|
GB0226727D0
(en)
|
2002-11-15 |
2002-12-24 |
Medical Res Council |
Intrabodies
|
|
WO2003086276A2
(en)
|
2002-04-05 |
2003-10-23 |
Selective Genetics, Inc. |
Compositions and methods for portal specific gene delivery and treatment of infection
|
|
CN103739706B
(zh)
|
2002-05-22 |
2015-11-18 |
艾斯巴技术-诺华有限责任公司 |
在胞内环境中表现出增强的稳定性的免疫球蛋白构架及其鉴定方法
|
|
US7119200B2
(en)
|
2002-09-04 |
2006-10-10 |
Schering Corporation |
Pyrazolopyrimidines as cyclin dependent kinase inhibitors
|
|
GB0226731D0
(en)
|
2002-11-15 |
2002-12-24 |
Medical Res Council |
Method for generating immunoglobulin genes
|
|
GB0226729D0
(en)
|
2002-11-15 |
2002-12-24 |
Medical Res Council |
Intracellular antibodies
|
|
JP2006521088A
(ja)
|
2002-11-15 |
2006-09-21 |
メディカル リサーチ カウンシル |
抗活性化ｒａｓ抗体
|
|
ITRM20020588A1
(it)
|
2002-11-21 |
2004-05-22 |
Lay Line Genomics Spa |
Metodo per isolare anticorpi intracellulari neutralizzanti di interazioni proteiche.
|
|
EP1482309A1
(en)
|
2003-05-07 |
2004-12-01 |
Institut Curie |
Means for detecting protein conformation and applications thereof
|
|
JP4053073B2
(ja)
|
2003-07-11 |
2008-02-27 |
ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー |
選択的ｃｄｋ４阻害剤のイセチオン酸塩
|
|
EP2302390B1
(en)
|
2003-07-15 |
2013-06-05 |
The Regents of The University of California |
Methods for detecting and analyzing n-glycolylneuraminic acid (Neu5Gc) specific antibodies in biological materials
|
|
ITMI20031909A1
(it)
|
2003-10-03 |
2005-04-04 |
Keryos Spa |
Linee cellulari di mammifero modificate per la produzione di glicoproteine ricombinanti.
|
|
CA2550933A1
(en)
|
2003-12-22 |
2005-07-14 |
Amgen Inc. |
Methods for identifying functional antibodies
|
|
JP2007527539A
(ja)
|
2004-03-05 |
2007-09-27 |
ザ スクリプス リサーチ インスティテュート |
ハイスループットグリカンマイクロアレイ
|
|
EP1740616B1
(en)
|
2004-04-30 |
2011-12-14 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Anti-tfr antibody.
|
|
KR100620554B1
(ko)
|
2004-06-05 |
2006-09-06 |
한국생명공학연구원 |
Ｔａｇ-72에 대한 인간화 항체
|
|
JP2008504531A
(ja)
|
2004-06-24 |
2008-02-14 |
ザ スクリップス リサーチ インスティテュート |
切断可能なリンカーを有するアレイ
|
|
US7638467B2
(en)
|
2004-08-03 |
2009-12-29 |
Intevep, S.A. |
Reversible gelling system and method using same during well treatments
|
|
US20060121042A1
(en)
|
2004-10-27 |
2006-06-08 |
Medimmune, Inc. |
Modulation of antibody specificity by tailoring the affinity to cognate antigens
|
|
WO2006068758A2
(en)
|
2004-11-19 |
2006-06-29 |
The Scripps Research Institute |
Detection, prevention and treatment of breast cancer
|
|
JP5255435B2
(ja)
|
2005-04-26 |
2013-08-07 |
メディミューン，エルエルシー |
ヒンジドメイン操作による抗体エフェクター機能の調節
|
|
WO2006117910A1
(ja)
|
2005-04-28 |
2006-11-09 |
Mochida Pharmaceutical Co., Ltd. |
抗血小板膜糖蛋白質ⅵモノクローナル抗体
|
|
AU2006254862B2
(en)
|
2005-06-08 |
2011-04-07 |
The Regents Of The University Of California |
Elimination of N-glycolylneuraminic acid from mammalian products for human use
|
|
CA2893252C
(en)
|
2005-08-24 |
2018-05-29 |
Immunogen, Inc. |
Process for preparing antibody maytansinoid conjugates
|
|
KR101624587B1
(ko)
|
2005-12-20 |
2016-05-26 |
에스비아이 바이오테크 가부시키가이샤 |
항-ｉｌｔ7 항체
|
|
WO2007079448A2
(en)
|
2006-01-03 |
2007-07-12 |
University Of Georgia Research Foundation, Inc. |
Three component carbohydrate vaccine
|
|
WO2010002478A2
(en)
|
2008-07-03 |
2010-01-07 |
University Of Georgia Research Foundation, Inc. |
Glycopeptide and uses thereof
|
|
ATE509027T1
(de)
|
2006-01-13 |
2011-05-15 |
Pasteur Institut |
Enzymatische synthese von grossen mengen von mucin glyconjugaten und deren immunogenische anwendungen
|
|
MX2008012013A
(es)
|
2006-03-23 |
2008-10-03 |
Novartis Ag |
Tratamiento con anticuerpo antigeno de celulas neoplasicas.
|
|
EP2000802A4
(en)
|
2006-03-31 |
2009-04-15 |
Mochida Pharm Co Ltd |
NOVEL MARKER FOR PLATELET ACTIVATION AND METHOD FOR DETERMINING THE SAME
|
|
US20070265170A1
(en)
|
2006-05-15 |
2007-11-15 |
Ola Blixt |
Detection, prevention and treatment of ovarian cancer
|
|
GB0613209D0
(en)
|
2006-07-03 |
2006-08-09 |
Ucb Sa |
Methods
|
|
JP2010505775A
(ja)
|
2006-10-04 |
2010-02-25 |
クーベンハヴンス・ユニヴェルシテット |
Ｍｕｃ１に対する癌特異的な免疫反応の産生及び癌特異的ｍｕｃ１抗体
|
|
WO2008070363A2
(en)
|
2006-10-31 |
2008-06-12 |
Domantis Limited |
Intrabodies
|
|
US20100104572A1
(en)
|
2006-11-02 |
2010-04-29 |
Sylvie Luria |
Methods for screening for therapeutic molecules and use of the molecules therefrom
|
|
WO2009018438A1
(en)
|
2007-07-31 |
2009-02-05 |
Cornell Research Foundation, Inc. |
Protein discovery using intracellular ribosome display
|
|
EP2014302A1
(en)
|
2007-07-12 |
2009-01-14 |
Institut Curie |
An antibody specific for the Tn antigen for the treatment of cancer
|
|
WO2009035494A2
(en)
|
2007-07-30 |
2009-03-19 |
The Scripps Research Institute |
Methods for producing anti-glycan antibodies, vaccines and methods for treating cancer or infectious disease
|
|
FI20070853A0
(fi)
|
2007-11-09 |
2007-11-09 |
Glykos Finland Oy |
Glykaania sitovat monoklonaaliset vasta-aineet
|
|
CA2705292C
(en)
|
2007-11-13 |
2016-06-21 |
Teva Biopharmaceuticals Usa, Inc. |
Humanized antibodies against tl1a
|
|
WO2009091826A2
(en)
|
2008-01-14 |
2009-07-23 |
The Board Of Regents Of The University Of Texas System |
Compositions and methods related to a human cd19-specific chimeric antigen receptor (h-car)
|
|
US20120027813A1
(en)
|
2008-02-22 |
2012-02-02 |
Novartis Vaccines And Diagnostics Srl |
Adjuvanted influenza vaccines for pediatric use
|
|
US8506966B2
(en)
|
2008-02-22 |
2013-08-13 |
Novartis Ag |
Adjuvanted influenza vaccines for pediatric use
|
|
US8298773B2
(en)
|
2008-05-02 |
2012-10-30 |
Marko Vuskovic |
Methods, assays and kits for cancer diagnosis and screening utilizing glycan-binding and glycan epitopes
|
|
EP2283862B1
(en)
|
2008-06-02 |
2018-08-08 |
The University of Tokyo |
Combination treatment of cancer comprising anti-mfg-e8 antibody
|
|
EP2143735A1
(en)
|
2008-07-10 |
2010-01-13 |
Institut Pasteur |
Variable domains of camelid heavy-chain antibodies directed against glial fibrillary acidic proteins
|
|
US20100009424A1
(en)
|
2008-07-14 |
2010-01-14 |
Natasha Forde |
Sonoporation systems and methods
|
|
FI20095418A0
(fi)
|
2009-04-16 |
2009-04-16 |
Suomen Punainen Risti Veripalv |
Kryptinen subpopulaatio
|
|
ES2522346T3
(es)
|
2008-08-22 |
2014-11-14 |
Novartis Ag |
Compuestos de pirrolopirimidina como inhibidores de CDK
|
|
AU2009291861A1
(en)
|
2008-09-09 |
2010-03-18 |
The Regents Of The University Of California |
Elimination of a contaminating non-human sialic acid by metabolic competition
|
|
US20120045816A1
(en)
|
2008-09-09 |
2012-02-23 |
Sialix, Inc. |
Novel Glycosylated Polypeptides
|
|
PA8852901A1
(es)
|
2008-12-22 |
2010-07-27 |
Lilly Co Eli |
Inhibidores de proteina cinasa
|
|
US20100178292A1
(en)
|
2009-01-12 |
2010-07-15 |
The Board Of Trustees Of The Leland Stanford Junior University |
Cryptic glycan markers and applications thereof
|
|
US8669085B2
(en)
|
2009-02-05 |
2014-03-11 |
Ut-Battelle, Llc |
Transformation of gram positive bacteria by sonoporation
|
|
US8524214B2
(en)
|
2009-05-28 |
2013-09-03 |
Mersana Therapeutics, Inc. |
Polyal drug conjugates comprising variable rate-releasing linkers
|
|
US8399624B1
(en)
|
2009-06-25 |
2013-03-19 |
Esbatech, An Alcon Biomedical Research Unit Llc |
Acceptor framework for CDR grafting
|
|
US9290577B2
(en)
|
2009-07-03 |
2016-03-22 |
Avipep Pty Limited |
Immuno-conjugates and methods for producing them
|
|
EP2275442A1
(en)
|
2009-07-06 |
2011-01-19 |
Ludwig-Maximilians-Universität München |
Detection and vizualization of the cell cycle in living cells
|
|
JP5769316B2
(ja)
|
2009-08-06 |
2015-08-26 |
イムナス・ファーマ株式会社 |
Ａβオリゴマーに特異的に結合する抗体およびその利用
|
|
EP2287202A1
(en)
*
|
2009-08-07 |
2011-02-23 |
Dublin City University |
Anti-sialic acid antibody molecules
|
|
EP2483301A1
(en)
|
2009-10-01 |
2012-08-08 |
The United States Of America, As Represented By The Secretary, Department of Health and Human Services |
Anti-vascular endothelial growth factor receptor-2 chimeric antigen receptors and use of same for the treatment of cancer
|
|
JP6184695B2
(ja)
|
2009-12-04 |
2017-08-23 |
ジェネンテック， インコーポレイテッド |
多重特異性抗体、抗体アナログ、組成物、及び方法
|
|
US20110177614A1
(en)
|
2010-01-15 |
2011-07-21 |
The Regents Of The University Of California |
Compositions and methods for detecting cancer
|
|
EP2347769A1
(en)
|
2010-01-20 |
2011-07-27 |
Glycotope GmbH |
Cancer stem cell markers and uses thereof
|
|
EP2565268A4
(en)
|
2010-04-28 |
2013-10-09 |
Shionogi & Co |
NEW MUC1 ANTIBODY
|
|
WO2011139974A2
(en)
|
2010-05-03 |
2011-11-10 |
Abbott Laboratories |
Anti-pai-1 antibodies and methods of use thereof
|
|
WO2011156751A2
(en)
|
2010-06-11 |
2011-12-15 |
University Of Georgia Research Foundation, Inc. |
Immunogenic vaccine
|
|
BR112013000776A2
(pt)
|
2010-07-13 |
2016-05-24 |
Ultragenyx Pharmaceutical Inc |
método e formulação para tratamento de deficiência de ácido siálico
|
|
EP2407487A1
(en)
|
2010-07-14 |
2012-01-18 |
F-Star Biotechnologische Forschungs - und Entwicklungsges. M.B.H. |
Multispecific modular antibody
|
|
EP2624868B1
(en)
|
2010-10-08 |
2018-09-26 |
City of Hope |
A monoclonal antibody framework binding interface for meditopes, meditope delivery systems and methods for their use
|
|
US20120115878A1
(en)
|
2010-11-10 |
2012-05-10 |
John Vincent Calienni |
Salt(s) of 7-cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7h-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid dimethylamide and processes of making thereof
|
|
PH12013501201A1
(en)
*
|
2010-12-09 |
2013-07-29 |
Univ Pennsylvania |
Use of chimeric antigen receptor-modified t cells to treat cancer
|
|
CN107267459A
(zh)
|
2011-01-06 |
2017-10-20 |
约翰·霍普金斯大学 |
在哺乳动物细胞中产生具有延长的循环半衰期的重组糖蛋白的方法
|
|
KR102257741B1
(ko)
|
2011-02-01 |
2021-05-28 |
에이치아이비엠 리서치 그룹, 인코포레이티드 |
시알산 생성을 증가시키고 시알릭 관련 질환 병증을 치료하기 위한 방법 및 조성물
|
|
US20140005069A1
(en)
|
2011-03-01 |
2014-01-02 |
Glycosensors And Diagnostics, Llc. |
Glycoprofiling with multiplexed suspension arrays
|
|
US9487583B2
(en)
|
2011-03-30 |
2016-11-08 |
National University Corporation University Of Toyama |
Method for selecting plasma cells or plasmablasts, method for producing target antigen specific antibodies, and novel monoclonal antibodies
|
|
KR101972303B1
(ko)
|
2011-06-10 |
2019-04-25 |
메르사나 테라퓨틱스, 인코포레이티드 |
단백질-중합체-약물 접합체
|
|
DK2744931T3
(en)
|
2011-08-18 |
2018-08-06 |
Affinity Biosciences Pty Ltd |
SOLUBLE POLYPEPTIDES
|
|
US10071129B2
(en)
|
2011-08-30 |
2018-09-11 |
Whitehead Institute For Biomedical Research Dana-Farber Cancer Institute, Inc. |
Method for identifying bromodomain inhibitors
|
|
SG11201400527XA
(en)
|
2011-09-16 |
2014-04-28 |
Univ Pennsylvania |
Rna engineered t cells for the treatment of cancer
|
|
WO2013055404A1
(en)
|
2011-10-10 |
2013-04-18 |
City Of Hope |
Meditopes and meditope-binding antibodies and uses thereof
|
|
WO2013074916A1
(en)
|
2011-11-18 |
2013-05-23 |
Board Of Regents, The University Of Texas System |
Car+ t cells genetically modified to eliminate expression of t- cell receptor and/or hla
|
|
DK2794658T3
(en)
|
2011-12-19 |
2017-06-19 |
Synimmune Gmbh |
BISPECIFIC ANTIBODY MOLECULE
|
|
TW201333040A
(zh)
|
2012-01-06 |
2013-08-16 |
Bioalliance Cv |
抗－輸鐵蛋白受器之抗體及其使用方法
|
|
CA2863799C
(en)
|
2012-02-22 |
2020-09-01 |
Matthew J. FRIGAULT |
Compositions and methods for generating a persisting population of t cells useful for the treatment of cancer
|
|
EP2825561A4
(en)
|
2012-03-15 |
2016-03-09 |
Permeon Biolog Inc |
CELL PENETRATING COMPOSITIONS FOR THE DISPOSAL OF INTRA-CELLULAR ANTIBODIES AND ANTIBODY-RELATED UNITS AND METHODS OF USE
|
|
WO2013151649A1
(en)
|
2012-04-04 |
2013-10-10 |
Sialix Inc |
Glycan-interacting compounds
|
|
EP4053162A1
(en)
|
2012-05-18 |
2022-09-07 |
Aptevo Research and Development LLC |
Bispecific scfv immunofusion (bif) binding to cd123 and cd3
|
|
AU2013302696B9
(en)
|
2012-08-14 |
2018-08-09 |
Ibc Pharmaceuticals, Inc. |
T-cell redirecting bispecific antibodies for treatment of disease
|
|
WO2014030780A1
(en)
|
2012-08-22 |
2014-02-27 |
Mogam Biotechnology Research Institute |
Screening and engineering method of super-stable immunoglobulin variable domains and their uses
|
|
US9937205B2
(en)
|
2012-09-04 |
2018-04-10 |
The Trustees Of The University Of Pennsylvania |
Inhibition of diacylglycerol kinase to augment adoptive T cell transfer
|
|
WO2014055771A1
(en)
|
2012-10-05 |
2014-04-10 |
The Trustees Of The University Of Pennsylvania |
Human alpha-folate receptor chimeric antigen receptor
|
|
MX388059B
(es)
|
2012-11-06 |
2025-03-19 |
Scholar Rock Inc |
Composiciones y metodos para modular la comunicacion celular.
|
|
US10226535B2
(en)
|
2012-12-10 |
2019-03-12 |
Mersana Therapeutics, Inc. |
Auristatin compounds and conjugates thereof
|
|
MX382301B
(es)
|
2012-12-24 |
2025-03-13 |
Abbvie Inc |
Proteinas de union al receptor de prolactina y usos de las mismas.
|
|
EP2752487A1
(en)
|
2013-01-03 |
2014-07-09 |
Sanofi |
Intracellular phenotypic screening
|
|
WO2014160360A1
(en)
|
2013-03-14 |
2014-10-02 |
Mersana Therapeutics Inc. |
Tubulysin compounds and conjugates thereof
|
|
KR20150130349A
(ko)
|
2013-03-15 |
2015-11-23 |
메르크 파텐트 게엠베하 |
4가 이중특이적 항체
|
|
KR102090356B1
(ko)
|
2013-03-15 |
2020-03-18 |
메모리얼 슬로안 케터링 캔서 센터 |
다량체화 기술
|
|
ES2800602T3
(es)
|
2013-07-23 |
2021-01-04 |
Ohio State Innovation Foundation |
Procedimientos y composiciones relacionados con los fragmentos de anticuerpos monocatenarios que se unen a la glucoproteína 72 asociada a tumor (TAG-72)
|
|
WO2015048748A1
(en)
|
2013-09-30 |
2015-04-02 |
Board Of Regents, The University Of Texas System |
Myeloid-derived suppressor cell-specific peptides for diagnostic and therapeutic use
|
|
WO2015054600A2
(en)
|
2013-10-10 |
2015-04-16 |
Siamab Therapeutics, Inc. |
Glycan-interacting compounds and methods of use
|
|
EP3114222B1
(en)
|
2014-03-04 |
2020-04-22 |
Sigma Aldrich Co. LLC |
Viral resistant cells and uses thereof
|
|
GB201406767D0
(en)
|
2014-04-15 |
2014-05-28 |
Cancer Rec Tech Ltd |
Humanized anti-Tn-MUC1 antibodies anf their conjugates
|
|
SMT202100116T1
(it)
|
2014-05-28 |
2021-05-07 |
Agenus Inc |
Anticorpi anti-gitr e metodi di utilizzo degli stessi
|
|
TWI695011B
(zh)
|
2014-06-18 |
2020-06-01 |
美商梅爾莎納醫療公司 |
抗ｈｅｒ２表位之單株抗體及其使用之方法
|
|
MA40364A
(fr)
|
2014-08-27 |
2016-03-03 |
Oncomed Pharm Inc |
Polythérapie pour le traitement du cancer
|
|
EP3204537A4
(en)
|
2014-10-10 |
2018-08-08 |
Siamab Therapeutics, Inc. |
Glycan analysis and profiling
|
|
WO2016057916A1
(en)
*
|
2014-10-10 |
2016-04-14 |
Siamab Therapeutics, Inc. |
Glycan-interacting compounds and methods of use
|
|
US9879087B2
(en)
*
|
2014-11-12 |
2018-01-30 |
Siamab Therapeutics, Inc. |
Glycan-interacting compounds and methods of use
|
|
IL278574B2
(en)
|
2014-11-12 |
2024-11-01 |
Seagen Inc |
Glycan-interacting compounds and methods of use
|
|
US20180334490A1
(en)
|
2014-12-03 |
2018-11-22 |
Qilong H. Wu |
Methods for b cell preconditioning in car therapy
|
|
MX391249B
(es)
|
2015-03-17 |
2025-03-21 |
Memorial Sloan Kettering Cancer Center |
Anticuerpos anti-muc16 y sus usos.
|
|
EP3091032A1
(en)
|
2015-05-08 |
2016-11-09 |
Miltenyi Biotec GmbH |
Humanized antibody or fragment thereof specific for cd3
|
|
WO2016201240A1
(en)
|
2015-06-12 |
2016-12-15 |
Siamab Therapeutics, Inc. |
Compositions and methods for targeting cancer stem cells
|
|
WO2017083582A1
(en)
|
2015-11-12 |
2017-05-18 |
Siamab Therapeutics, Inc. |
Glycan-interacting compounds and methods of use
|
|
WO2017132486A1
(en)
|
2016-01-27 |
2017-08-03 |
Siamab Therapeutics, Inc. |
Compositions and methods for targeting cancer stem cells
|
|
WO2018094143A1
(en)
|
2016-11-17 |
2018-05-24 |
Siamab Therapeutics, Inc. |
Glycan-interacting compounds and methods of use
|
|
US20200247902A1
(en)
|
2016-11-17 |
2020-08-06 |
Seattle Genetics, Inc. |
Compositions and methods for treating cancer
|
|
KR20240044544A
(ko)
|
2017-03-03 |
2024-04-04 |
씨젠 인크. |
글리칸-상호작용 화합물 및 사용 방법
|